The inhibition of angiogenesis by targeting Smo is consistent with earlier studies demonstrating a pro-angiogenic role for Hh on ischemic tissues [29], [47], embryonic vasculogenesis [59], [60], as well as in tumor [58]. Here, SMO is linked to neoplasm.